LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) EBT Margin (2014 - 2026)

LivaNova's (LIVN) quarterly EBT Margin came in at 4.73% in Q2 2026, down 472.0% year-over-year from 1.27% in Q2 2025, and down 37.64% quarter-over-quarter from 7.59% in Q1 2026.

Analysis

LivaNova (LIVN) EBT Margin (2014 - 2026) Analysis & Trends

LivaNova has disclosed EBT Margin across 13 years of filings, most recently posting 4.73% for Q2 2026.

  • In Q2 2026, EBT Margin fell 472.0% year-over-year to 4.73%; the TTM figure through Jun 2026 stood at 7.31% (up 2116.0% YoY), while the FY2025 annual figure was 15.91%, down 2295.0% from the prior year.
  • EBT Margin came in at 4.73% for Q2 2026 at LivaNova, down from 7.59% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 17.55% in Q4 2024 to a low of 99.62% in Q1 2025.
  • Average EBT Margin over 5 years is 4.97%, with a median of 4.22% recorded in 2023.
  • Year-over-year, EBT Margin slumped 8802 bps in 2025 and jumped 10721 bps in 2026.
  • Over 5 years, EBT Margin stood at 2.33% in 2022, then slumped by 1407 bps to 30.41% in 2023, then surged by 158 bps to 17.55% in 2024, then plunged by 56 bps to 7.66% in 2025, then slumped by 38 bps to 4.73% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 4.73% in Q2 2026, 7.59% in Q1 2026, and 7.66% in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 12.10%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 36.46%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 18.13%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 23.74%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 19.48%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 29.86%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -1.65%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 24.27%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 18.32%
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn 4.73%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.73%
Mar 31, 2026 7.59%
Dec 31, 2025 7.66%
Sep 30, 2025 9.48%
Jun 30, 2025 9.45%
Mar 31, 2025 -99.62%
Dec 31, 2024 17.55%
Sep 30, 2024 13.97%
Jun 30, 2024 6.78%
Mar 31, 2024 -11.60%
Dec 31, 2023 -30.41%
Sep 30, 2023 -0.69%
Jun 30, 2023 1.80%
Mar 31, 2023 3.71%
Dec 31, 2022 2.33%
Sep 30, 2022 -42.00%
Jun 30, 2022 7.48%
Mar 31, 2022 2.32%
Dec 31, 2021 -0.85%
Sep 30, 2021 -16.41%